Upcoming Events
August 29-31, 2019
The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum for discussion and debates on current management options for men with advanced prostate cancer in these unclear situations. Two days of the conference are dedicated to high-level presentations, discussions and debates, summarizing and conceptualizing the available literature and evidence.
The conference concludes with voting by the panel on pre-defined consensus questions, targeting areas of clinical relevance. Following the conference a manuscript with containing the expert recommendations is published in a peer reviewed journal (2015 Annals of Oncology, 2017 European Urology).

Aims of APCCC

  • Provide an update on the current standard of advanced prostate cancer management with a focus on situations with no high level evidence for a specific treatment option.
  • Advanced prostate cancer is defined by APCCC as locally advanced disease and men with biochemical recurrence or metastatic disease.
  • Program is highly educational, consisting of invited lectures, debates and discussions led by the panel of international and interdisciplinary prostate cancer experts.
  • The entire conference is focused on “knowledge translation” by summarising and conceptualising the current standards of advanced prostate cancer management and disseminating the results of the consensus discussions and votings.
  • The conference will culminate with an interdisciplinary expert consensus panel meeting that will discuss and vote on predefined questions relating to key areas where there is lack of evidence or conflict regarding the optimal treatment of men with advanced prostate cancer. The process of the conference and the development of the questions have been described in detail (Ref APCCC 2015 und APCCC 2017).
  • Participants will be able to attend the two days of the discussions as well as the voting of the panellists as part of the conference.
  • The consensus summary is published after the meeting in a high impact medical journal.
  • Attendees will be able to interact with panel members, facilitating and encouraging international collaboration.

See APCCC 2017 Coverage

Preview of the APCCC 2019 - Interview with Silke Gillessen
Silke Gillessen, in conversation with Alicia Morgans provides an overview of many of the changes we are experiencing in clinical practice since the 2017 APCCC. 
September 11-14, 2019
Swissôtel Chicago, IL

93rd Annual Meeting of the North Central Section of the AUA

September 11 - 14, 2019

Swissotel Chicago
Chicago, IL

More Information Coming Soon!
October 24-27, 2019
November 7-9, 2019
London, England
MAP 2019 -  Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice.

The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology.  The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.

Organised by Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, the MAP Congress is the result of an enduring collaborative effort and offers its delegates the very latest thinking in the field.

We look forward to seeing you in London!

Target Audience 
Medical oncologists, young professionals, PhDs, academics, regulators, industry R&D representatives and investigators and all those interested in the clinical interpretation of molecular tests to providing effective cancer treatment and deliver Precision Medicine.

Location information:
Queen Elizabeth II Centre
Country: United Kingdom
City: SW1P 3EE London
Street: Broad Sanctuary - Westminster
February 13-15, 2020

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.